Ethereum treasury company Propanc Biopharma reaches up to $100 million strategic financing agreement with Hexstone Capital
ChainCatcher reported that Propanc Biopharma, a biopharmaceutical company adopting an Ethereum treasury strategy, has announced a strategic financing agreement with family office Hexstone Capital for up to $100 million. Propanc CEO James Nathanielsz stated that this financing will accelerate the development of the company’s clinical pipeline, and they plan to grow the value of their digital asset treasury to $100 million or more within the next 12 months.
Hexstone Capital has previously invested in several companies with digital asset treasuries, involving BTC, ETH, SOL, DOGE, and other digital assets. According to previous reports, in early September Propanc Biopharma announced plans to acquire $100 million worth of Ethereum.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BoE’s Greene says it is appropriate to proactively tighten our monetary policy stance
CoreWeave plans to issue at least $4 billion in investment-grade loans, falling nearly 6% after hours
According to Bloomberg, CoreWeave is seeking to refinance at least 4 billion USD through an investment-grade loan, led by Morgan Stanley and Mitsubishi UFJ, with a syndication roadshow expected to start as soon as next week. This financing continues the structure of using Nvidia chips and customer contracts as collateral, with the yield on the issuance anticipated to be around 7% to 7.5%, much lower than its junk bond yield. Following the news, CoreWeave's shares fell nearly 5.8% after hours.
Outperformed the S&P by 19.2 percentage points in one month: Berkshire (BRK.B) achieves its highest monthly relative advantage since 2010, second only to the 2008 financial crisis
As the AI trading boom subsides and technology stocks waver, one of the market’s oldest “safe havens” has once again proven its value. Berkshire Hathaway (BRK.B) has just recorded one of its most notable relative gains in over a decade.
Crypto prices
More
